Previous Article | Next Article 
Journal of Virology, April 2007, p. 3807-3815, Vol. 81, No. 8
0022-538X/07/$08.00+0 doi:10.1128/JVI.02795-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation
Hendrik Huthoff and
Michael H. Malim*
Department of Infectious Diseases, King's College London School of Medicine, London, United Kingdom
Received 19 December 2006/
Accepted 19 January 2007
The human immunodeficiency virus type-1 (HIV-1) accessory protein Vif serves to neutralize the human antiviral proteins apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G [A3G]) and A3F. As such, the therapeutic blockade of Vif function represents a logical objective for rational drug design. To facilitate such endeavors, we have employed molecular genetics to define features of A3G that are required for its interaction with Vif. Using alanine-scanning mutations and multiple different substitutions at key residues, we confirm the central role played by the aspartic acid at position 128 and identify proline 129 and aspartic acid 130 as important contributory residues. The overall negative charge of this 3-amino-acid motif appears critical for recognition by Vif, as single lysine substitutions are particularly deleterious and a double alanine substitution at positions 128 and 130 is far more inhibitory than single-residue mutations at either position. Our analyses also reveal that the immediately adjacent 4 amino acids, residues 124 to 127, are important for the packaging of A3G into HIV-1 particles. Most important are tyrosine 124 and tryptophan 127, and mutations at these positions can ablate virion incorporation, as well as the capacity to inhibit virus infection. Thus, while pharmacologic agents that target the acidic motif at residues 128 to 130 have the potential to rescue A3G expression by occluding recognition by Vif, care will have to be taken not to perturb the contributions of the neighboring 124-to-127 region to packaging if such agents are to have therapeutic benefit by promoting A3G incorporation into progeny virions.
* Corresponding author. Mailing address: Department of Infectious Diseases, King's College London School of Medicine, 2nd Floor, New Guy's House, Guy's Hospital, London Bridge, London SE1 9RT, United Kingdom. Phone: 44 0 20 7188 0149. Fax: 44 0 20 7188 0147. E-mail:
michael.malim{at}kcl.ac.uk
Published ahead of print on 31 January 2007.
Journal of Virology, April 2007, p. 3807-3815, Vol. 81, No. 8
0022-538X/07/$08.00+0 doi:10.1128/JVI.02795-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bulliard, Y., Turelli, P., Rohrig, U. F., Zoete, V., Mangeat, B., Michielin, O., Trono, D.
(2009). Functional Analysis and Structural Modeling of Human APOBEC3G Reveal the Role of Evolutionarily Conserved Elements in the Inhibition of Human Immunodeficiency Virus Type 1 Infection and Alu Transposition. J. Virol.
83: 12611-12621
[Abstract]
[Full Text]
-
Iwatani, Y., Chan, D. S. B., Liu, L., Yoshii, H., Shibata, J., Yamamoto, N., Levin, J. G., Gronenborn, A. M., Sugiura, W.
(2009). HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain. Proc. Natl. Acad. Sci. USA
106: 19539-19544
[Abstract]
[Full Text]
-
Chelico, L., Pham, P., Petruska, J., Goodman, M. F.
(2009). Biochemical Basis of Immunological and Retroviral Responses to DNA-targeted Cytosine Deamination by Activation-induced Cytidine Deaminase and APOBEC3G. J. Biol. Chem.
284: 27761-27765
[Abstract]
[Full Text]
-
Chen, G., He, Z., Wang, T., Xu, R., Yu, X.-F.
(2009). A Patch of Positively Charged Amino Acids Surrounding the Human Immunodeficiency Virus Type 1 Vif SLVx4Yx9Y Motif Influences Its Interaction with APOBEC3G. J. Virol.
83: 8674-8682
[Abstract]
[Full Text]
-
Dang, Y., Wang, X., Zhou, T., York, I. A., Zheng, Y.-H.
(2009). Identification of a Novel WxSLVK Motif in the N Terminus of Human Immunodeficiency Virus and Simian Immunodeficiency Virus Vif That Is Critical for APOBEC3G and APOBEC3F Neutralization. J. Virol.
83: 8544-8552
[Abstract]
[Full Text]
-
Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R.
(2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev.
73: 211-232
[Abstract]
[Full Text]
-
Green, L. A., Liu, Y., He, J. J.
(2009). Inhibition of HIV-1 Infection and Replication by Enhancing Viral Incorporation of Innate Anti-HIV-1 Protein A3G: A NON-PATHOGENIC Nef MUTANT-BASED ANTI-HIV STRATEGY. J. Biol. Chem.
284: 13363-13372
[Abstract]
[Full Text]
-
Malim, M. H
(2009). APOBEC proteins and intrinsic resistance to HIV-1 infection. Phil Trans R Soc B
364: 675-687
[Abstract]
[Full Text]
-
Russell, R. A., Smith, J., Barr, R., Bhattacharyya, D., Pathak, V. K.
(2009). Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif. J. Virol.
83: 1992-2003
[Abstract]
[Full Text]
-
Bennett, R. P., Salter, J. D., Liu, X., Wedekind, J. E., Smith, H. C.
(2008). APOBEC3G Subunits Self-associate via the C-terminal Deaminase Domain. J. Biol. Chem.
283: 33329-33336
[Abstract]
[Full Text]
-
Bogerd, H. P., Cullen, B. R.
(2008). Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation. RNA
14: 1228-1236
[Abstract]
[Full Text]
-
Bennett, R. P., Presnyak, V., Wedekind, J. E., Smith, H. C.
(2008). Nuclear Exclusion of the HIV-1 Host Defense Factor APOBEC3G Requires a Novel Cytoplasmic Retention Signal and Is Not Dependent on RNA Binding. J. Biol. Chem.
283: 7320-7327
[Abstract]
[Full Text]
-
Wang, T., Tian, C., Zhang, W., Luo, K., Sarkis, P. T. N., Yu, L., Liu, B., Yu, Y., Yu, X.-F.
(2007). 7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G. J. Virol.
81: 13112-13124
[Abstract]
[Full Text]